Search tips
Search criteria 


Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
Sci Rep. 2017; 7: 43729.
Published online 2017 March 2. doi:  10.1038/srep43729
PMCID: PMC5333092

Depletion of Gangliosides Enhances Articular Cartilage Repair in Mice


Elucidation of the healing mechanisms in damaged tissues is a critical step for establishing breakthroughs in tissue engineering. Articular cartilage is clinically one of the most successful tissues to be repaired with regenerative medicine because of its homogeneous extracellular matrix and few cell types. However, we only poorly understand cartilage repair mechanisms, and hence, regenerated cartilage remains inferior to the native tissues. Here, we show that glycosylation is an important process for hypertrophic differentiation during articular cartilage repair. GM3, which is a precursor molecule for most gangliosides, was transiently expressed in surrounding damaged tissue, and depletion of GM3 synthase enhanced cartilage repair. Gangliosides also regulated chondrocyte hypertrophy via the Indian hedgehog pathway. These results identify a novel mechanism of cartilage healing through chondrocyte hypertrophy that is regulated by glycosylation. Manipulation of gangliosides and their synthases may have beneficial effects on articular cartilage repair.

Over 200 million people worldwide suffer from osteoarthritis (OA), which is characterized by the progressive breakdown of articular cartilage1,2 and ultimately leads to the functional failure of synovial joints. Because articular cartilage has a limited potential for regeneration, many attempts have been made to enhance cartilage healing to prevent OA pathogenesis3,4,5. However, the regenerated cartilage in these attempts is considered to be inferior compared with native cartilage tissue.

One reason for the difficulty in improving cartilage regeneration is our poor understanding of the mechanism of articular cartilage repair. Regarding OA pathogenesis, several mechanisms of articular cartilage degradation have been shown in OA mouse models6,7,8,9. In contrast, the molecular mechanism of articular cartilage repair is not fully understood because until recently, no appropriate mouse model was available. A cartilage healing mouse model has been established that allows analysis of the cartilage regeneration process10. Elucidation of the cartilage repair process is essential for optimal manipulation of articular cartilage regeneration.

Glycans regulate various metabolic pathways including those that are active in cartilage tissue11,12. Glycosphingolipids (GSLs) are a group of glycolipids that are widely distributed on vertebrate plasma membranes. These molecules form clusters on cell membranes where they modulate transmembrane signaling and mediate cell-to-cell and cell-to-matrix interactions13,14. GSLs comprise diverse types of glycolipids and are classified into several groups. Among these groups, gangliosides are the most abundant GSLs in cartilage15 and play roles in maintaining chondrocyte homeostasis16 and differentiation17. In addition, the total ganglioside content in OA cartilage is decreased by 40%18,19, suggesting that gangliosides play a dominant role in cartilage metabolism and differentiation.

Therefore, we hypothesize that gangliosides regulate cartilage differentiation and/or metabolism during the reparative process of damaged articular cartilage. To test this hypothesis, we first investigated the normal expression pattern of GM3, which is a precursor molecule for most complex ganglioside species. We subsequently employed a strain of mice that are genetically engineered to lack GM3 synthase (GM3S; GM3−/− mice) and are practically ganglioside deficient. The final goal of the current study was to clarify the functional role of gangliosides in articular cartilage repair.


The normal expression pattern of GM3 during the articular cartilage repair process and chondrogenic differentiation

We previously reported that among the GSLs, the ganglio-series was most abundant in cartilage15. Here we analyzed the ganglio-series and showed that GM3, which serves as a precursor molecule for gangliosides, was the most abundant ganglioside (relative expression; 23%, Supplemental Fig. 1) in cartilage. Then we analyzed the localization of GM3 during the articular cartilage repair process after osteochondral injury (injury model) using wild-type (WT) mice10. GM3 was transiently increased surrounding the repaired tissue, with a peak 6 weeks postoperative (Fig. 1A–L), suggesting that GM3 plays important roles in the late phase of the articular cartilage repair process. In an in vitro experiment, we also analyzed the localization of GM3 during chondrogenic differentiation from mesenchymal stem cells (MSCs). GM3 was transiently increased at days 21 and 28, and then declined at day 42 (Fig. 2). These results suggested that GM3 plays important roles in the late phase such as the hypertrophic process.

Figure 1
GM3 expression after osteochondral injury in WT mice (AL). Four weeks (AD), 6 weeks (EH), and 8 weeks (IL) after osteochondral injury. GM3 expression in 8-week-old GM3−/− mice (M,N). White dotted lines ...
Figure 2
GM3 expression during chondrogenic differentiation (AL). Day 21 (AD), day 28 (EH), day 42 (IL). Representative histology with Alcian blue staining at 21 days (M), 28 days (N), and 42 days (O). The scale bars show 100 μm. ...

Depletion of gangliosides in mice enhances articular cartilage repair

We next analyzed articular cartilage repair at 8 weeks postoperative in 4-week-old mice (n = 9). GM3−/− mice showed superior cartilage repair compared to WT mice (Fig. 3A–F). The repair score for the articular joint surface was significantly higher in GM3−/− mice than WT mice (4-week-old: mean ± standard error of the mean (SEM); 7.1 ± 0.81 in WT mice versus 11 ± 0.63 in GM3−/− mice [P = 0.00020], Fig. 3G). We also examined repair in 8-week-old mice. However, the repaired tissue in adult GM3−/− mice was fibrous tissue at best. Therefore, we used 4-week-old mice in further experiments (8-week-old: mean ± SEM; 2.1 ± 0.24 in WT mice versus 5.1 ± 0.79 in GM3−/− mice [P = 0.0079], Supplemental Fig. 2E). In addition, we conducted quantitative histomorphometry analysis in 4-week-old mice as previously reported20. The histomorphometry analysis clearly showed that the repaired tissue in GM3−/− mice showed higher Safranin O staining than repaired tissue in WT mice. (%Saf-O: mean ± SEM; 43 ± 3.3 in WT mice versus 70 ± 4.9 in GM3−/− mice [P < 0.0001]) (Fig. 3H). The high Safranin O staining of the hyaline cartilage matrix suggests that depletion of gangliosides may help improve the biomechanical properties.

Figure 3
Eight weeks postoperative in 4-week-old mice.

Immunostaining analysis shows that depletion of gangliosides suppresses the expression of hypertrophy-related genes

At 8 weeks postoperative, we found no significant difference in type II collagen staining between WT and GM3−/− mice (Fig. 4A,G). Type X collagen in WT mice showed staining to some extent that surrounded the repaired tissue, whereas the staining of type X collagen in GM3−/− mice was less intense (Fig. 4B,H). Although we could not detect the expression of Runt-related transcription factor (Runx)3 or Matrix metalloprotease (MMP)13 in repaired tissue, the expression of Runx2 and Indian hedgehog (Ihh) in GM3−/− mice surrounding repaired tissue was suppressed compared to WT mice (Fig. 4C–F,I–L).

Figure 4
Immunostaining analysis of articular cartilage repair 8 weeks postoperative.

Depletion of gangliosides does not affect the cell population

The above data revealed that articular cartilage injuries in GM3−/− mice were repaired well due to suppression of chondrocyte hypertrophy surrounding the repaired tissue. This raised the possibility that depletion of gangliosides suppresses chondrocyte hypertrophy. To test this hypothesis, we performed a functional assay with MSCs and chondrocytes. The in vitro cell proliferation assay showed no significant difference between cells obtained from WT and GM3−/− mice after 24 h (MSCs; mean ± SEM; 0.46 ± 0.027 in WT mice versus 0.51 ± 0.028 in GM3−/− mice [P = 0.29], chondrocytes; 0.36 ± 0.013 in WT mice versus 0.37 ± 0.0049 in GM3−/− mice [P = 0.28]; n = 6) (Supplemental Fig. 3). The wound healing assay also showed no significant difference between cells obtained from WT and GM3−/− mice after 6 h (mean ± SEM; 0.12 ± 0.016 mm2 in WT mice versus 0.11 ± 0.0075 mm2 in GM3−/− mice [P = 0.67], chondrocytes; 0.18 ± 0.013 in WT mice versus 0.16 ± 0.022 in GM3−/− mice [P = 0.49]; n = 6) (Supplemental Fig. 4). Next, we analyzed how depletion of gangliosides affected the MSC population. Although the expression of type II collagen, Runx2, and Runx3 mRNA in MSCs was higher in GM3−/− mice (Supplemental Fig. 5A–F), fluorescence activated cell sorting (FACS) analysis showed that the expression of stem cell markers was almost equal between WT and GM3−/− mice (Supplemental Fig. 5G,H).

Analysis of chondrogenic differentiation shows that depletion of gangliosides suppresses the expression of type X collagen via the Ihh pathway

Because the above data suggested that depletion of gangliosides did not affect the cell population, we investigated how depletion of gangliosides affected the chondrogenic program. In chondrogenic differentiation from MSCs, we observed no significant difference in Alcian blue staining or type II collagen (Fig. 5A,B,D,E). Staining for type X collagen was lower in GM3−/− mice than in WT mice (Fig. 5C,F). During chondrogenic differentiation from MSCs, expression of chondrocyte-specific genes such as type II collagen and aggrecan mRNA increased with time in WT and GM3−/− mice (Fig. 5G,H). At day 28, type II collagen mRNA was significantly upregulated in GM3−/− mice (mean ± SEM; 1.7 ± 0.20 in WT mice versus 7.1 ± 0.54 in GM3−/− mice [P < 0.0001] Fig. 4G), whereas aggrecan mRNA was not significantly different between WT mice and GM3−/− mice (98 ± 13 in WT mice versus 87 ± 30 in GM3−/− mice [P = 0.76] Fig. 5H). Type X collagen mRNA was significantly decreased in GM3−/− mice (2.2 ± 0.78 versus 0.17 ± 0.047 [P = 0.041] Fig. 5I). The effect of depletion of gangliosides on expression of hypertrophy-related genes was also determined. Runx2 and 3 and Ihh mRNA were significantly decreased in GM3−/− mice (Runx2: 2.0 ± 0.19 in WT mice versus 0.33 ± 0.071 in GM3−/− mice [P < 0.0001], Runx3: 0.77 ± 0.0.20 in WT mice versus 0.25 ± 0.050 in GM3−/− mice [P = 0.047], Ihh: 240 ± 29 versus 130 ± 26 [P = 0.023], Fig. 5J–L).

Figure 5
Chondrogenic differentiation from mouse MSCs.

Analysis of hypertrophic differentiation in chondrocytes also shows that depletion of gangliosides suppresses the expression of type X collagen via the Ihh pathway

To ask whether the role of gangliosides surrounding the repair site is cell-type specific for chondrocytes, we examined how the loss of gangliosides affected in vitro differentiation of murine primary chondrocytes to the terminal hypertrophic state. Interestingly, the expression of hypertrophy-related genes (type X collagen, Runx family, and Ihh) in GM3−/− mice was significantly decreased after 14 days of induction (type X collagen: 2.9 ± 0.21 in WT mice versus 0.46 ± 0.064 in GM3−/− mice [P < 0.0001], Runx2: 4.2 ± 0.25 in WT mice versus 2.5 ± 0.35 in GM3−/− mice [P = 0.0025], Runx3: 1.6 ± 0.20 in WT mice versus 0.58 ± 0.072 in GM3−/− mice [P = 0.0010], Ihh: 36 ± 5.8 versus 4.2 ± 0.73 [P = 0.00030], Fig. 6).

Figure 6
Quantitative real-time reverse transcription-polymerase chain reaction analysis of in vitro differentiation of murine primary chondrocytes.

Overexpression of GM3S enhances expression of hypertrophy-related genes in chondrocytes via the Ihh pathway

Finally, to confirm whether gangliosides regulate chondrocyte hypertrophy, we overexpressed GM3S in mouse chondrocytes. Transient transfection of GM3S in WT chondrocytes showed that GM3S mRNA expression was significantly upregulated in chondrocytes with the GM3S plasmid vector compared to those with the mock vector (mean ± SEM; mock: 0.0022 ± 0.0014, GM3S: 2200 ± 410 [P = 0.0046]; n = 4, Fig. 7A). Type X collagen, Runx2, and Ihh mRNAs were significantly increased in chondrocytes with the GM3S plasmid vector (type X collagen: mock: 0.0011 ± 0.00013, GM3S: 0.0023 ± 0.00036 [P = 0.049], Runx2: mock: 0.010 ± 0.0010, GM3S: 0.020 ± 0.0039 [P = 0.0071], Ihh: mock: 0.00047 ± 0.000064, GM3S: 0.0012 ± 0.00017 [P = 0.012], Fig. 7B,C,E). Runx3 mRNA tended to increase in chondrocytes with the GM3S plasmid vector (Runx3: mock: 0.010 ± 0.00086 versus GM3S: 0.015 ± 0.0023 [P = 0.13], Fig. 7D). In addition, transient transfection of GM3S in GM3−/− mouse chondrocytes showed no significant differences, but similar trends were observed (GM3S; mock: 0.0011 ± 0.0014, GM3S: 4.5 ± 0.95 [P = 0.0025] type X collagen: mock: 0.000084 ± 0.000026, GM3S: 0.00019 ± 0.000041 [P = 0.087], Runx2: mock: 0.026 ± 0.0042, GM3S: 0.032 ± 0.0036 [P = 0.32], Runx3: mock: 0.017 ± 0.0021 versus GM3S: 0.029 ± 0.0038 [P = 0.035], Ihh: mock: 0.00043 ± 0.00016, GM3S: 0.00066 ± 0.00010 [P = 0.30], Fig. 7F–J). Although, a direct comparison of these results with GM3 expression in vivo is extremely difficult, these results are consistent with the in vivo results showing that chondrocyte hypertrophy surrounding repaired tissue was regulated by the expression of gangliosides.

Figure 7
Association of the overexpression of GM3 synthase (GM3S) with hypertrophic-related genes.


Time-sequential immunostaining after osteochondral injury revealed that GM3 expression was transiently enhanced surrounding the injury site during the late phase of the articular cartilage repair process. The distribution of GM3 expression strongly suggests that GM3 is involved in the cartilage healing process. Because our data showed that depletion of gangliosides suppresses chondrocyte hypertrophy, we were also interested in bone metabolism and/or remodeling. Thus, we investigated the depth of the cartilage in the repair site. However, the measurements were almost equal between WT and GM3−/− mice (Supplemental Fig. 6). Based on these results, we believe that the effect of ganglioside depletion in bone is less than the effect in cartilage.

The expression pattern of only a few molecules has been investigated during the articular cartilage repair process. The chemokine stromal cell-derived factor 1 is transiently upregulated during the early phase and plays a role in recruitment of bone marrow stromal cells during articular cartilage repair21. Tenascin-C, a member of the extracellular matrix glycoprotein family, is also transiently increased during the early phase of articular cartilage repair and promotes chondrogenesis during the reparative process22. However, no previous reports have described transient enhancement during the late phase of the articular cartilage repair process. To the best of our knowledge, GM3 is the first molecule identified that was transiently enhanced during the late phase of the articular cartilage repair process.

Based on the transient enhancement of GM3 during the late phase after osteochondral injury, we speculated that gangliosides play important roles in late chondrogenic differentiation including hypertrophy rather than cell migration and proliferation. To test our hypothesis, we first evaluated cell migration and proliferation of cells from WT and GM3−/− mice. Our results predictably revealed no difference in cell migration or proliferation, whereas the depletion of gangliosides suppressed chondrocyte hypertrophic differentiation. Chondrocyte hypertrophy, which eventually results in ectopic ossification, is an unresolved issue in cartilage tissue engineering23,24. Chondrogenesis without chondrocyte hypertrophy is required to organize and maintain reparative hyaline cartilage. Manipulation of GM3 function may overcome this issue and avoid chondrocyte hypertrophy with strict regulation.

Although the depletion of gangliosides accelerates cartilage degradation15, GM3−/− mice unexpectedly showed accelerated articular cartilage repair in our current study. As mentioned above, inhibition of chondrocyte hypertrophy enhances cartilage regeneration. Therefore, this inhibition may become a therapeutic strategy for articular cartilage repair5,25. The roles of hypertrophic differentiation during articular cartilage repair differ from those during cartilage degradation. Previous reports using genetically modified mice showed that enhancement of chondrocyte hypertrophy was frequently associated with a higher incidence of OA or acceleration of OA26,27,28. On the other hand, hypertrophic differentiation is a common compensatory reaction against mechanical stress to prevent cartilage degeneration29. Regarding the OA pathogenesis in GM3−/− mice, we speculate that inhibition of chondrocyte hypertrophy disrupted resistance to mechanical stress rather than accelerated cartilage repair15,30.

Ihh, a member of the Hedgehog family of proteins, is essential for growth plate formation and chondrocyte maturation via Runx2 and Runx3 expression31. Regarding OA pathogenesis, a genetic study in mice showed that conditional deletion of Ihh in chondrocytes attenuates OA progression, suggesting that blockade of Ihh signaling may be useful as a therapeutic approach to prevent or delay cartilage degeneration32. However, Ihh gene deletion is currently not a therapeutic option as it is lethal in animals33. In the current study, GM3−/− mice showed enhanced articular cartilage repair via suppression of Ihh signals. GM3−/− mice develop normally without serious systemic effects15,34, suggesting that the ganglioside-mediated approach to modifying the Ihh pathway is a novel gene therapy strategy that may have less influence on systemic conditions.

Several limitations to this study must be considered when interpreting the present results. First, although we used the osteochondral injury model for the analysis of the articular cartilage repair process, how the MSCs from the subchondral bone are involved in the current study remains unclear. Because identification of the cells in the articular cartilage repair sites is difficult, the cells that mainly produce the matrix were assumed to be chondrocytes surrounding repaired tissue. To ask whether MSCs participate in this phenomenon, we examined chondrogenic differentiation from murine MSCs, and results showed that depletion of gangliosides suppressed chondrocyte hypertrophy in MSCs. In addition, depletion of gangliosides in chondrocytes suppressed hypertrophic differentiation. We were unable to identify the origin of chondrocytes in the current study. However, taking into account the transient enhancement of GM3 surrounding repaired tissue in the late phase, we speculate that the GM3-positive cells mainly differentiated into hypertrophic chondrocytes. This point should be addressed in future studies. Second, we investigated the articular cartilage repair process using young mice because we and others have previously reported that the healing potential of adult C57BL/6 mice is limited10,35,36. Although the mechanisms of articular cartilage repair may vary with age, we believe that the healing mechanisms of articular cartilage in immature mice will provide important insights that will be applicable to the manipulation of cartilage healing in adults. Third, how gangliosides regulate the expression of chondrogenic-related genes remains unclear. Gangliosides are widely distributed in vertebrate plasma membranes and act as modulators of various types of transmembrane signaling. Because gangliosides do not have any specific ligands, conducting functional analysis using ganglioside-null mice is extremely difficult. The chondrocytes surrounding repaired tissue show increased tendency toward to hypertrophic differentiation (Fig. 4), suggesting that gangliosides specifically act when the cellular metabolic activity is enhanced. However, from the current study, we can conclude that gangliosides participate in the articular cartilage repair process by suppressing chondrocyte hypertrophy. This issue should be addressed in future studies.

To the best of our knowledge, this is the first study to reveal that gangliosides regulate hypertrophic differentiation of chondrocytes. Depletion of gangliosides enhanced the articular cartilage repair process via the Ihh pathway. Although a future study is needed to ensure consistency with OA, inhibition of hypertrophic differentiation may be a future strategy for accelerating cartilage repair.


Animals and generation of gene-deleted mice

GM3−/− mice were generated as described previously34. C57BL/6 mice were purchased from Japan SLC, Inc. (Shizuoka, Japan) and used as WT mice. Mice were utilized after acclimatization for 7 days following transportation37. All purchased mice returned to their normal behavior within 24 h after transportation. The mice used in the current study were housed in a temperature- and humidity-controlled environment under 12-h light/12-h dark conditions and fed a standard rodent diet. All animal experiments were performed in accordance with protocols approved by the Institute of Animal Care and Use Committee of the Hokkaido University Graduate School of Medicine.

Generation of articular cartilage injuries

Articular cartilage full-thickness injuries were generated in 4-week-old and 8-week-old female mice10. Briefly, the two ends of 21-G needles were cut to create an outer cylinder that was adjusted to be approximately 300 μm shorter than a 27-G needle, and this original device was used to create the injury. Longitudinal full-thickness injuries along the femoral axis were made in the patellar groove using the ends of the needles of the device described above.

Tissue processing and histology

At each postoperative period, the knee joints were fixed with 10% formalin (WAKO, Tokyo, Japan), and then decalcified with ethylenediaminetetraacetic acid, embedded in paraffin, and sectioned at 5-μm thicknesses. Histological sections were made as previously reported10,35. Briefly, axial sections were made at three points per knee joint to make sure the articular cartilage repair site was included. The first section was 100 μm proximal to the intercondylar notch, the second one was another 100 μm proximal to the first section, and the third one was 100 μm proximal to the second section. The sections at each point were used for histomorphometry and scoring. All slides were analyzed using an Olympus DP72 camera and DP2-BSW software (Olympus, Tokyo, Japan).

Macroscopic and histological evaluations of articular cartilage repair

The animals were euthanized for further investigation at 8 weeks postoperative. The knee samples were photographed using a Nikon SMZ745T (Nikon, Tokyo, Japan). Each section was stained with hematoxylin & eosin and Safranin-O staining. The histological score for joint surface repair of each section was evaluated as previously reported10,38. The scoring was performed independently by two blinded observers. Quantitative histomorphometry of Safranin O-stained sections was performed using Image J software (National Institutes of Health, Bethesda, MD, USA) as previously reported20. The total region of the articular cartilage repair site was defined and measured as the total repair tissue volume. The percent Safranin O-stained repaired tissue in the total soft tissue volume (%Saf-O) was obtained. The depth of the cartilage in the repaired tissue was measured at 8 weeks postoperative using Image J software. All data are presented as the means ± standard error of the mean (SEM).

Isolation of MSCs and chondrocytes

MSCs were harvested from the compact bone of 2-week-old mice as previously reported39 and cultured in alpha Modified Eagle Minimum Essential Medium (Sigma, St. Louis, MO) with 2 mM l-glutamine, 1% antibiotics (WAKO), and 10% fetal bovine serum (NICHIREI, Tokyo, Japan). Immature mouse chondrocytes were obtained from the knee joints of newborn mice as previously described40. Chondrocytes were cultured in Dulbecco’s modified Eagle’s medium (WAKO) with 10% fetal bovine serum (NICHIREI) and 1% antibiotics (WAKO).

Quantification of GSL-glycans in the chondrocytes by mass spectrometry

GSLs were recovered from mouse chondrocyte pellets by chloroform-methanol extraction, and GSL-glycans were released by endoglycoceramidase digestion as previously reported15. Released intact GSL-glycans were subjected to a glycoblotting procedure and matrix-assisted laser desorption ionization-time-of-flight/time-of-flight mass spectrometry analysis.

In vitro cell viability assay

To investigate the effects of ganglioside deficiency on cellular viability, mouse MSCs or chondrocytes were cultured in 96-well tissue plates in growth medium. The number of viable cells at each time was counted with Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan) by quantification of the absorbance at 450 nm.

In vitro wound healing assay

To investigate cell motility, an assay described previously was used with slight modifications41. Briefly, mouse MSCs or chondrocytes were cultured to confluent monolayers in 6-well tissue plates in growth medium and subsequently wounded by uniform scratching with a pipette tip. This initial wounding and the movement of the cells into the blank field of the scratch line after 6 h were photographically documented using an Olympus IX71 microscope (Olympus). The migration rate was calculated as the reduction area, which remained cell-free after scratching between both borderlines. Images were obtained using Image J software.


Total RNA was extracted from the samples using the RNeasy Mini kit (Qiagen, Hilden, Germany). For complementary DNA synthesis, 1.0 μg RNA was reverse transcribed using random hexamer primers (Promega, Tokyo, Japan) and ImProm II reverse transcriptase (Promega). QPCR was performed using a Thermal Cycler Dice Real Time System II (Takara Bio Inc., Otsu, Japan). Signals were detected using SYBR Premix Ex Taq II (Takara) with gene-specific primers (Supplementary Table 1). The relative mRNA expression of each targeted gene was expressed as the Ct value of each gene normalized to the Ct value of GAPDH by using the δδCt method42.

Flow cytometry

We quantitatively investigated the population difference between WT and GM3−/− mice. MSCs (1 × 106) were stained with FITC-conjugated anti-mouse CD45 (eBioscience, USA), PE-conjugated anti-mouse CD29 (eBioscience), or PE-conjugated CD86 antibodies (eBioscience). Cell surface marker expression was analyzed by flow cytometry (FACSCanto, BD Biosciences, San Jose, CA, USA).

Chondrogenic differentiation of MSCs

MSCs (1 × 106) were placed in polypropylene tubes and centrifuged at a speed of 300 × g for 6 min. The pellets were cultured in 1 ml complete chondrogenic medium consisting of Dulbecco’s modified Eagle’s medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 10−7 M dexamethasone (Sigma), 1% insulin-transferrin-sodium selenium (Sigma), 50 μM ascorbate-2-phosphate (WAKO), 50 μg/ml proline (WAKO), 20 ng/ml transforming growth factor-β3 (Life Technologies), and 1% antibiotics (WAKO)39. The polypropylene tubes were maintained at 37 °C in a 5% CO2 incubator, and the medium was changed every 3 days. The pellets were used for immunostaining or qPCR at each time. Data were normalized to the average mRNA level at day 0 (set at 1) and are presented as means ± SEM.

Hypertrophic differentiation of chondrocytes

Mouse chondrocytes were seeded in 24-well tissue culture plates and cultured in Dulbecco’s modified Eagle medium–F-12 (WAKO) supplemented with 10% fetal bovine serum (NICHIREI), 1% ITS Media supplement (containing insulin, transferrin, and selenous acid; Sigma), and 50 μg/ml ascorbate-2-phosphate (WAKO) for the indicated times. The cells were maintained at 37 °C in a 5% CO2 incubator with medium changes every 48 h. Data were normalized to the average mRNA level at day 0 (set at 1) and are presented as means ± SEM.


Sections were deparaffinized, and endogenous peroxidase activity was quenched. Sections were incubated with rabbit polyclonal antibodies against rat type II collagen (1:50; Daiichi Fine Chemical, Toyama, Japan), type X collagen (1:200; LSL, Tokyo, Japan), Runx2 (1:100; Santa Cruz Biotechnology, Waltham, MA, USA), Runx3 (1:100; Cell Signaling Technology, Beverly, MA, USA), Ihh (1:250; Abcam, Cambridge, MA, USA), and MMP-13 (1:100; Abcam). After washing with phosphate-buffered saline three times, the samples were incubated with a biotinylated secondary antibody and visualized by the precipitation of diaminobenzidine (DAKO, Copenhagen, Denmark).

Preparation of frozen sections and immunostaining for GM3

We prepared frozen sections at each time point from the samples43. Sections were incubated with the primary antibody anti-GM3 (M2590, 1:100; Cosmo Bio, Tokyo, Japan), and staining was visualized with an Alexa 594-conjugated anti-rabbit IgM antibody (1:1000; Life Technologies)17. Negative control sections were incubated with iso-type matched control serum (1:100; DAKO). Nuclei were stained with DAPI (Dojindo, Kumamoto, Japan). All slides were analyzed with confocal laser scanning microscopy (Olympus Fluoview FV300).

Alcian blue staining

The cells were rinsed with phosphate-buffered saline twice, fixed with 95% methanol, and then stained with Alcian blue (pH 2.5, Muto Pure Chemicals, Tokyo, Japan) for 60 min. Then, cells were washed with 3% acetic acid for 3 min and photographed.

Plasmid preparation and transient transfection

Plasmid vectors were designed by and purchased from Ori-Gene (Rockville, MD). The expression vector for GM3S was St3gal5 (NM_001035228). The mouse cDNA clone was OriGene MC209401, and the mock control vector was pCMV6-Entry (OriGene PS100001). Mouse chondrocytes were seeded in 24-well tissue culture plates. After the chondrocytes reached subconfluency, the cells were transfected using Lipofectamine LTX (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. After 48 h, the cells were used for analysis.

Statistical analysis

Mean histological scores were statistically compared with non-parametric Wilcoxon tests between pairs of groups. Statistical comparison of data between the two groups of samples was performed with unpaired t tests. Significance was accepted with a P value < 0.05. All statistical analyses were done using statistical software JMP Pro 11.0 (SAS Institute, Cary, NC, USA).

Additional Information

How to cite this article: Matsuoka, M. et al. Depletion of Gangliosides Enhances Articular Cartilage Repair in Mice. Sci. Rep. 7, 43729; doi: 10.1038/srep43729 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplemental Figure:


This study was supported by The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care.


The authors declare no competing financial interests.

Author Contributions Experimental Design, T.O. and N.I.; Experiments, M.M., K.H., F.S., and J.F.; Data Analysis, M.M., T.O., K.H., F.S., D.M., R.B., K.H., Z.J., S.M., T.Y., and N.I.; Manuscript, M.M., T.O., and N.I. All authors discussed the results and commented on the manuscript.


  • Lin A. C. et al. . Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15, 1421–1425, doi: (2009).10.1038/nm.2055 [PubMed] [Cross Ref]
  • Arai M. et al. . Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system. Osteoarthritis Cartilage 12, 599–613, doi: .10.1016/j.joca.2004.05.001 [PubMed] [Cross Ref]
  • Jakobsen R. B., Engebretsen L. & Slauterbeck J. R. An analysis of the quality of cartilage repair studies. The Journal of bone and joint surgery. American volume 87, 2232–2239, doi: (2005).10.2106/JBJS.D.02904 [PubMed] [Cross Ref]
  • Knutsen G. et al. . Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. The Journal of bone and joint surgery. American volume 86-A, 455–464 (2004). [PubMed]
  • Huey D. J., Hu J. C. & Athanasiou K. A. Unlike bone, cartilage regeneration remains elusive. Science, doi: (2012).10.1126/science.1222454 [PMC free article] [PubMed] [Cross Ref]
  • Ohta Y. et al. . Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg. Arthritis Rheumatol, doi: (2015).10.1002/art.39243 [PubMed] [Cross Ref]
  • Matsui Y. et al. . Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 60, 2362–2371, doi: (2009).10.1002/art.24705 [PubMed] [Cross Ref]
  • Kamekura S. et al. . Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13, 632–641, doi: S1063-4584(05)00077-4 (2005). [PubMed]
  • Goldring M. B. & Goldring S. R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. N. Y. Acad. Sci. 1192, 230–237, doi: (2010).10.1111/j.1749-6632.2009.05240.x [PubMed] [Cross Ref]
  • Matsuoka M. et al. . An Articular Cartilage Repair Model in Common C57Bl/6 Mice. Tissue engineering. Part C, Methods 21, 767–772, doi: (2015).10.1089/ten.TEC.2014.0440 [PMC free article] [PubMed] [Cross Ref]
  • Dwek R. A. Glycobiology: Toward Understanding the Function of Sugars. Chem Rev 96, 683–720 (1996). [PubMed]
  • Dalziel M., Crispin M., Scanlan C. N., Zitzmann N. & Dwek R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 343, 1235681, doi: (2014).10.1126/science.1235681 [PubMed] [Cross Ref]
  • Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265, 18713–18716 (1990). [PubMed]
  • Regina Todeschini A. & Hakomori S. I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780, 421–433, doi: (2008).10.1016/j.bbagen.2007.10.008 [PMC free article] [PubMed] [Cross Ref]
  • Sasazawa F. et al. . Depletion of gangliosides enhances cartilage degradation in mice. Osteoarthritis Cartilage 22, 313–322, doi: (2014).10.1016/j.joca.2013.11.015 [PubMed] [Cross Ref]
  • Seito N. et al. . Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice. Arthritis Rheum, doi: (2012).10.1002/art.34463 [PMC free article] [PubMed] [Cross Ref]
  • Kamasaki Y. et al. . Glycosphingolipids regulate ameloblastin expression in dental epithelial cells. J Dent Res 91, 78–83, doi: 0022034511424408 012. [PubMed]
  • David M. J. et al. . Characterization of gangliosides from normal and osteoarthritic human articular cartilage. Arthritis Rheum 36, 938–942 (1993). [PubMed]
  • David M. J. et al. . Gangliosides from normal and osteoarthritic joints. J Rheumatol Suppl 43, 133–135 (1995). [PubMed]
  • Chen H. et al. . Depth of subchondral perforation influences the outcome of bone marrow stimulation cartilage repair. J Orthop Res 29, 1178–1184, doi: (2011).10.1002/jor.21386 [PubMed] [Cross Ref]
  • Sukegawa A. et al. . Repair of Rabbit Osteochondral Defects by an Acellular Technique with an Ultrapurified Alginate Gel Containing Stromal Cell-Derived Factor-1. Tissue Eng Part A, doi: (2012).10.1089/ten.TEA.2011.0380 [PubMed] [Cross Ref]
  • Okamura N. et al. . Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage 18, 839–848, doi: (2010).10.1016/j.joca.2009.08.013 [PubMed] [Cross Ref]
  • Mithoefer K., McAdams T., Williams R. J., Kreuz P. C. & Mandelbaum B. R. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. The American journal of sports medicine 37, 2053–2063, doi: (2009).10.1177/0363546508328414 [PubMed] [Cross Ref]
  • Steck E. et al. . Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage. Stem cells and development 18, 969–978, doi: (2009).10.1089/scd.2008.0213 [PubMed] [Cross Ref]
  • van der Kraan P. M. & van den Berg W. B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 20, 223–232, doi: (2012).10.1016/j.joca.2011.12.003 [PubMed] [Cross Ref]
  • Kamekura S. et al. . Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 54, 2462–2470, doi: (2006).10.1002/art.22041 [PubMed] [Cross Ref]
  • Saito T. & Kawaguchi H. HIF-2alpha as a possible therapeutic target of osteoarthritis. Osteoarthritis and cartilage/OARS, Osteoarthritis Research Society 18, 1552–1556, doi: (2010).10.1016/j.joca.2010.10.006 [PubMed] [Cross Ref]
  • Yang S. et al. . Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat. Med. 16, 687–693, doi: (2010).10.1038/nm.2153 [PubMed] [Cross Ref]
  • Nathan M., Pope M. H. & Grobler L. J. Osteophyte formation in the vertebral column: a review of the etiologic factors–Part II. Contemp Orthop 29, 113–119 (1994). [PubMed]
  • Tsukuda Y. et al. . Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis. PLoS One 7, e40136, doi: (2012).10.1371/journal.pone.0040136 [PMC free article] [PubMed] [Cross Ref]
  • Yoshida C. A. et al. . Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18, 952–963, doi: (2004).10.1101/gad.1174704 [PubMed] [Cross Ref]
  • Zhou J., Wei X. & Wei L. Indian Hedgehog, a critical modulator in osteoarthritis, could be a potential therapeutic target for attenuating cartilage degeneration disease. Connect Tissue Res 55, 257–261, doi: (2014).10.3109/03008207.2014.925885 [PubMed] [Cross Ref]
  • St-Jacques B., Hammerschmidt M. & McMahon A. P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13, 2072–2086 (1999). [PubMed]
  • Yamashita T. et al. . Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A 100, 3445–3449, doi: (2003).10.1073/pnas.0635898100 [PubMed] [Cross Ref]
  • Eltawil N. M., De Bari C., Achan P., Pitzalis C. & Dell’accio F. A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage 17, 695–704, doi: (2009).10.1016/j.joca.2008.11.003 [PMC free article] [PubMed] [Cross Ref]
  • Fitzgerald J. et al. . Evidence for articular cartilage regeneration in MRL/MpJ mice. Osteoarthritis Cartilage 16, 1319–1326, doi: 1016/j.joca.2008.03.014 (2008). [PubMed]
  • Obernier J. A. & Baldwin R. L. Establishing an appropriate period of acclimatization following transportation of laboratory animals. ILAR J 47, 364–369 (2006). [PubMed]
  • Wakitani S. et al. . Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76, 579–592 (1994). [PubMed]
  • Zhu H. et al. . A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 5, 550–560, doi: (2010).10.1038/nprot.2009.238 [PubMed] [Cross Ref]
  • Gosset M., Berenbaum F., Thirion S. & Jacques C. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 3, 1253–1260, doi: (2008).10.1038/nprot.2008.95 [PubMed] [Cross Ref]
  • Liang C. C., Park A. Y. & Guan J. L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329–333, doi: (2007).10.1038/nprot.2007.30 [PubMed] [Cross Ref]
  • Pei M., Li J. T., Shoukry M. & Zhang Y. A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering. Eur Cell Mater 22, 333–343; discussion 343, doi: (2011). [PubMed]
  • Li J. W. et al. . In vitro chondrogenesis of the goat bone marrow mesenchymal stem cells directed by chondrocytes in monolayer and 3-dimetional indirect co-culture system. Chin Med J (Engl) 124, 3080–3086 (2011). [PubMed]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group